NCCN Corporate Council

The NCCN Corporate Council is an important resource for the development and expansion of NCCN programs and resources. NCCN offers membership in the NCCN Corporate Council in order to significantly enhance collaborative efforts between NCCN and health care companies.  Members include pharmaceutical, biotechnology, and diagnostics companies, as well as health information technology organizations. 

Membership

NCCN Corporate Council Membership may include attendance at the semi-annual Corporate Council meetings, complimentary registration to NCCN educational programming, complimentary tuition to NCCN Academy for Excellence & Leadership in Oncology™, subscriptions to NCCN Flash Updates™, and receipt of the NCCN Corporate Council Newsletter. Membership also allows for regular communication with NCCN throughout the year. Memberships may be customized to include additional programming, such as support of and attendance to NCCN Policy Summits, commercial offerings at NCCN conferences and meetings, licensing of and permission for NCCN Content, and NCCN Trends™ questions.

For additional information on the NCCN Corporate Council please contact Beth Gaffney, MBA, Vice President, US & Global Business Development.

Meetings

The next NCCN Corporate Council Meeting will take place on Wednesday, October 9, 2024, in Scottsdale, AZ.

NCCN Corporate Council Members

NCCN gratefully acknowledges the support and commitment of the following companies to the improvement of the treatments available to the patients whom we all serve. We also appreciate the recognition of NCCN's necessary autonomy in all decision-making regarding the conclusions, recommendations and outcomes of NCCN programs and resources.

 

  • abbvie company logo
  • acrotech company logo
  • ADCT  company logo
  • ADCT  company logo
  • ambry  company logo
  • amgen  company logo
  • Amneal Pharmaceuticals
  • apo biologix  company logo
  • Arvinas
  • astellas  company logo
  • astraZeneca  company logo
  • Autolus
  • bayer  company logo
  • BeiGene  company logo
  • blueprint medicines company logo
  • Boehringer company logo
  • bms  company logo title=
  • bms  company logo title=
  • Castle  company logo
  • Cencora
  • Coherus  Solutions
  • daiichi-sankyo  company logo
  • dcph-logo-registered-rgb
  • dendreon  company logo
  • eisai  company logo
  • Elevar Therapeutics company logo
  • EMD  company logo
  • Exact Sciences company logo
  • exelixis  company logo

  • Ferring Pharmaceuticals
  • foundation Medicine company logo
  • genettech  company logo title=
  • Genmab  company logo
  • Geron
  • Gilead Sciences Logo
  • Grail
  • GSK  company logo
  • guardant  company logo
  • hologic  company logo
  • Illumina
  • Immunogen
  • incyte  company logo
  • Invitae  company logo
  • ipsen  company logo
  • janssen company logo
  • jazz  company logo
  • karyo company logo
  • Kite Pharma company logo
  • kyowa kirin company logo
  • Lantheus
  • lilly company logo
  • merck  company logo
  • myriad  company logo
  • natera  company logo
  • novarts company logo
  • novocure company logo
  • Paxman  company logo
  • pfizer company logo
  • pharma essentia company logo
  • phrma  company logo
  • Precise DX
  • regeneron company logo
  • Rigel Pharmaceuticals
  • sandoz company logo
  • sanofi company logo
  • Servier company logo
  • SpringWorks Therapeutics
  • stemline  company logo
  • sunpharma company logo
  • sunpharma company logo
  • taiho company logo
  • takeda company logo
  • TerSera  company logo
  • TerSera  company logo
  • Decipher Bio  company logo

Global NCCN Corporate Council

NCCN is grateful for the support of our Global NCCN Corporate Council Members. To view a full list of NCCN Global Corporate Council Members, click here.

For additional information on the NCCN Global Corporate Council, please contact James McCanney, JD, Director, Business Development.

For additional opportunities to support NCCN, please visit the Supporter Opportunities section of our website.